» Articles » PMID: 30274346

LP1 from C Induces Autophagy, Apoptosis and Reduces Metastasis in Human Gastric Cancer Cell Line SGC-7901

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2018 Oct 3
PMID 30274346
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Present study aimed to elucidate the anticancer effect and the possible molecular mechanism underlying the action of Latcripin 1 (LP1), from the mushroom strain C against gastric cancer cell lines SGC-7901 and BGC-823. Cell viability was measured by Cell Counting Kit-8 (CCK-8); morphological changes were observed by phase contrast microscope; autophagy was determined by transmission electron microscope and fluorescence microscope. Apoptosis and cell cycle were assessed by flow cytometer; wound-healing, transwell migration and invasion assays were performed to investigate the effect of LP1 on gastric cancer cell's migration and invasion. Herein, we found that LP1 resulted in the induction of autophagy by the formation of autophagosomes and conversion of light chain 3 (LC3I into LC3II. LP1 up-regulated the expression level of autophagy-related gene (Atg7, Atg5, Atg12, Atg14) and Beclin1; increased and decreased the expression level of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) proteins respectively, along with the activation of Caspase-3. At lower-doses, LP1 have shown to arrest cells in the S phase of the cell cycle and decreased the expression level of matrix metalloproteinase MMP-2 and MMP-9. In addition, it has also been shown to regulate the phosphorylation of one of the most hampered gastric cancer pathway, that is, protein kinase B/mammalian target of rapamycin (Akt/mTOR) channel and resulted in cell death. These findings suggested LP1 as a potential natural anti-cancer agent, for exploring the gastric cancer therapies and as a contender for further in vitro and in vivo investigations.

Citing Articles

Effects of plant-based medicinal food on postoperative recurrence and lung metastasis of gastric cancer regulated by Wnt/β-catenin-EMT signaling pathway and VEGF-C/D-VEGFR-3 cascade in a mouse model.

Tian L, Chen X, Cao L, Zhang L, Chen J BMC Complement Med Ther. 2022; 22(1):233.

PMID: 36056333 PMC: 9438347. DOI: 10.1186/s12906-022-03703-0.


Potential Therapeutic Action of Autophagy in Gastric Cancer Managements: Novel Treatment Strategies and Pharmacological Interventions.

Rahman M, Ahmed K, Rahman M, Park M, Kim B Front Pharmacol. 2022; 12:813703.

PMID: 35153766 PMC: 8834883. DOI: 10.3389/fphar.2021.813703.


Potential of Bioactive Food Components against Gastric Cancer: Insights into Molecular Mechanism and Therapeutic Targets.

Kang S, Hwang D, Shin S, Park J, Kim M, Rahman M Cancers (Basel). 2021; 13(18).

PMID: 34572730 PMC: 8469857. DOI: 10.3390/cancers13184502.


Combining the Anticancer and Immunomodulatory Effects of and Shiitake as an Integrated Therapeutic Approach.

Balakrishnan B, Liang Q, Fenix K, Tamang B, Hauben E, Ma L Nutrients. 2021; 13(8).

PMID: 34444724 PMC: 8401741. DOI: 10.3390/nu13082564.


A plant-based medicinal food inhibits the growth of human gastric carcinoma by reversing epithelial-mesenchymal transition via the canonical Wnt/β-catenin signaling pathway.

Chen X, Yue W, Tian L, Li N, Chen Y, Zhang L BMC Complement Med Ther. 2021; 21(1):137.

PMID: 33964908 PMC: 8106854. DOI: 10.1186/s12906-021-03301-6.


References
1.
Adams J, Cory S . The Bcl-2 protein family: arbiters of cell survival. Science. 1998; 281(5381):1322-6. DOI: 10.1126/science.281.5381.1322. View

2.
Kim M, Jeong E, Ahn C, Kim S, Lee S, Yoo N . Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol. 2008; 39(7):1059-63. DOI: 10.1016/j.humpath.2007.11.013. View

3.
Liu J, Zhou X, Chen J, Yi G, Chen H, Ba M . Up-regulation of PIK3CA promotes metastasis in gastric carcinoma. World J Gastroenterol. 2010; 16(39):4986-91. PMC: 2957609. DOI: 10.3748/wjg.v16.i39.4986. View

4.
Venerito M, Nardone G, Selgrad M, Rokkas T, Malfertheiner P . Gastric cancer--epidemiologic and clinical aspects. Helicobacter. 2014; 19 Suppl 1:32-7. DOI: 10.1111/hel.12164. View

5.
Bilici A . Treatment options in patients with metastatic gastric cancer: current status and future perspectives. World J Gastroenterol. 2014; 20(14):3905-15. PMC: 3983446. DOI: 10.3748/wjg.v20.i14.3905. View